Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Goate

Showing results (91-100 of 289) with videos related to

Pageof 29
Sort By:
Molecular Neurodegeneration|September 26, 2021
Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaquesPranav Preman, Julia Tcw, Sara Calafate, et al.
Alzheimer Disease and Associated Disorders|November 17, 2016
Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease NeuropathologySarah E Monsell, Charles Mock, David W Fardo, et al.
Annals of Neurology|August 2, 2003
Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindredPau Pastor, Catherine M Roe, Andrés Villegas, et al.
Neurobiology of Disease|January 15, 2022
APOE4 confers transcriptomic and functional alterations to primary mouse microgliaSaima I Machlovi, Sarah M Neuner, Brittany M Hemmer, et al.
Alcoholism, Clinical and Experimental Research|December 18, 2014
Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humansYuri A Blednov, Jillian M Benavidez, Mendy Black, et al.
Acta Neuropathologica|July 21, 2009
TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathyMichael A Gitcho, Eileen H Bigio, Manjari Mishra, et al.
Archives of Neurology|August 10, 2011
Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer diseaseCarlos Cruchaga, Petra Nowotny, John S K Kauwe, et al.
Journal of Molecular Neuroscience : MN|May 24, 2011
FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathyTristan Page, Michael A Gitcho, Sabrina Mosaheb, et al.
Biological Psychiatry|February 20, 2014
Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluidOscar Harari, Carlos Cruchaga, John S K Kauwe, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2008
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta depositionJohn S K Kauwe, Carlos Cruchaga, Kevin Mayo, et al.
Pageof 29

Showing results (91-100 of 289) with videos related to

Sort By:
Pageof 29
Molecular Neurodegeneration|September 26, 2021
Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaquesPranav Preman, Julia Tcw, Sara Calafate, et al.
Alzheimer Disease and Associated Disorders|November 17, 2016
Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease NeuropathologySarah E Monsell, Charles Mock, David W Fardo, et al.
Annals of Neurology|August 2, 2003
Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindredPau Pastor, Catherine M Roe, Andrés Villegas, et al.
Neurobiology of Disease|January 15, 2022
APOE4 confers transcriptomic and functional alterations to primary mouse microgliaSaima I Machlovi, Sarah M Neuner, Brittany M Hemmer, et al.
Alcoholism, Clinical and Experimental Research|December 18, 2014
Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humansYuri A Blednov, Jillian M Benavidez, Mendy Black, et al.
Acta Neuropathologica|July 21, 2009
TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathyMichael A Gitcho, Eileen H Bigio, Manjari Mishra, et al.
Archives of Neurology|August 10, 2011
Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer diseaseCarlos Cruchaga, Petra Nowotny, John S K Kauwe, et al.
Journal of Molecular Neuroscience : MN|May 24, 2011
FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathyTristan Page, Michael A Gitcho, Sabrina Mosaheb, et al.
Biological Psychiatry|February 20, 2014
Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluidOscar Harari, Carlos Cruchaga, John S K Kauwe, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2008
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta depositionJohn S K Kauwe, Carlos Cruchaga, Kevin Mayo, et al.
Pageof 29